Sphere-9 Can Ablate VT in Europe While Its US Pivotal Is Still Enrolling

Sphere-9 Can Ablate VT in Europe While Its US Pivotal Is Still Enrolling

Medtronic can sell Sphere-9 into ventricular tachycardia in Europe while the trial meant to prove it works in the US is only now enrolling.